VI-RADS score system - A primer for urologists
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | International Braz J Urol (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382022000400609 |
Resumo: | ABSTRACT Bladder cancer (BCa) is one of the most common cancers worldwide and is also considered to be one of the most relapsing and aggressive neoplasms. About 30% of patients will present with muscle invasive disease, which is associated with a higher risk for metastatic disease. The aim of this article is to review the state of art imaging in Radiology, while providing a complete guide to urologists, with case examples, for the rationale of the development of the Vesical Imaging Reporting and Data System (VI-RADS), a scoring system emphasizing a standardized approach to multiparametric Magnetic Resonance Imaging (mpMRI) acquisition, interpretation, and reporting for BCa. Also, we examine relevant external validation studies and the consolidated literature of mpMRI for bladder cancer. In addition, this article discusses some of the potential clinical implications of this scoring system for disease management and follow-up. |
id |
SBU-1_2c86c9142a0d4d46937da5f92e00a0c9 |
---|---|
oai_identifier_str |
oai:scielo:S1677-55382022000400609 |
network_acronym_str |
SBU-1 |
network_name_str |
International Braz J Urol (Online) |
repository_id_str |
|
spelling |
VI-RADS score system - A primer for urologistsUrinary Bladder NeoplasmsDiffusion Magnetic Resonance ImagingGenitourinary Tract Anomalies [Supplementary Concept]ABSTRACT Bladder cancer (BCa) is one of the most common cancers worldwide and is also considered to be one of the most relapsing and aggressive neoplasms. About 30% of patients will present with muscle invasive disease, which is associated with a higher risk for metastatic disease. The aim of this article is to review the state of art imaging in Radiology, while providing a complete guide to urologists, with case examples, for the rationale of the development of the Vesical Imaging Reporting and Data System (VI-RADS), a scoring system emphasizing a standardized approach to multiparametric Magnetic Resonance Imaging (mpMRI) acquisition, interpretation, and reporting for BCa. Also, we examine relevant external validation studies and the consolidated literature of mpMRI for bladder cancer. In addition, this article discusses some of the potential clinical implications of this scoring system for disease management and follow-up.Sociedade Brasileira de Urologia2022-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382022000400609International braz j urol v.48 n.4 2022reponame:International Braz J Urol (Online)instname:Sociedade Brasileira de Urologia (SBU)instacron:SBU10.1590/s1677-5538.ibju.2021.0560info:eu-repo/semantics/openAccessNicola,RefkyPecoraro,MartinaLucciola,SaraReis,Rodolfo Borges dosNarumi,YoshifumiPanebianco,ValeriaMuglia,Valdair Franciscoeng2022-07-22T00:00:00Zoai:scielo:S1677-55382022000400609Revistahttp://www.brazjurol.com.br/ONGhttps://old.scielo.br/oai/scielo-oai.php||brazjurol@brazjurol.com.br1677-61191677-5538opendoar:2022-07-22T00:00International Braz J Urol (Online) - Sociedade Brasileira de Urologia (SBU)false |
dc.title.none.fl_str_mv |
VI-RADS score system - A primer for urologists |
title |
VI-RADS score system - A primer for urologists |
spellingShingle |
VI-RADS score system - A primer for urologists Nicola,Refky Urinary Bladder Neoplasms Diffusion Magnetic Resonance Imaging Genitourinary Tract Anomalies [Supplementary Concept] |
title_short |
VI-RADS score system - A primer for urologists |
title_full |
VI-RADS score system - A primer for urologists |
title_fullStr |
VI-RADS score system - A primer for urologists |
title_full_unstemmed |
VI-RADS score system - A primer for urologists |
title_sort |
VI-RADS score system - A primer for urologists |
author |
Nicola,Refky |
author_facet |
Nicola,Refky Pecoraro,Martina Lucciola,Sara Reis,Rodolfo Borges dos Narumi,Yoshifumi Panebianco,Valeria Muglia,Valdair Francisco |
author_role |
author |
author2 |
Pecoraro,Martina Lucciola,Sara Reis,Rodolfo Borges dos Narumi,Yoshifumi Panebianco,Valeria Muglia,Valdair Francisco |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Nicola,Refky Pecoraro,Martina Lucciola,Sara Reis,Rodolfo Borges dos Narumi,Yoshifumi Panebianco,Valeria Muglia,Valdair Francisco |
dc.subject.por.fl_str_mv |
Urinary Bladder Neoplasms Diffusion Magnetic Resonance Imaging Genitourinary Tract Anomalies [Supplementary Concept] |
topic |
Urinary Bladder Neoplasms Diffusion Magnetic Resonance Imaging Genitourinary Tract Anomalies [Supplementary Concept] |
description |
ABSTRACT Bladder cancer (BCa) is one of the most common cancers worldwide and is also considered to be one of the most relapsing and aggressive neoplasms. About 30% of patients will present with muscle invasive disease, which is associated with a higher risk for metastatic disease. The aim of this article is to review the state of art imaging in Radiology, while providing a complete guide to urologists, with case examples, for the rationale of the development of the Vesical Imaging Reporting and Data System (VI-RADS), a scoring system emphasizing a standardized approach to multiparametric Magnetic Resonance Imaging (mpMRI) acquisition, interpretation, and reporting for BCa. Also, we examine relevant external validation studies and the consolidated literature of mpMRI for bladder cancer. In addition, this article discusses some of the potential clinical implications of this scoring system for disease management and follow-up. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-08-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382022000400609 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382022000400609 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/s1677-5538.ibju.2021.0560 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Urologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Urologia |
dc.source.none.fl_str_mv |
International braz j urol v.48 n.4 2022 reponame:International Braz J Urol (Online) instname:Sociedade Brasileira de Urologia (SBU) instacron:SBU |
instname_str |
Sociedade Brasileira de Urologia (SBU) |
instacron_str |
SBU |
institution |
SBU |
reponame_str |
International Braz J Urol (Online) |
collection |
International Braz J Urol (Online) |
repository.name.fl_str_mv |
International Braz J Urol (Online) - Sociedade Brasileira de Urologia (SBU) |
repository.mail.fl_str_mv |
||brazjurol@brazjurol.com.br |
_version_ |
1750318078345871360 |